
REXCLAV 457 DS
Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)

Amoxicillin & Potassium Clavulanate Tablets I.P.
Potent broad-spectrum antibacterial formulation combining Amoxicillin with Clavulanic Acid to combat beta-lactamase resistant pathogens.
500 mg + 125 mg (625 mg)
10 × 10 Tablets
Rs. 205.00
Schedule H Rx
Each film-coated tablet contains:
Lower respiratory tract infections (acute bronchitis, pneumonia)
Acute bacterial sinusitis & otitis media
Skin and soft tissue infections
Urinary tract infections
REXCLAV 625 provides definitive empiric therapy for moderate-to-severe community-acquired infections. The Potassium Clavulanate addition acts as an irreversible suicide inhibitor of bacterial beta-lactamase enzymes, restoring Amoxicillin full antimicrobial potency.
Standard Adult / Pediatric Regimen:
1 tablet twice daily with meals or strictly as directed by the physician.
Disclaimer: Dosage must be strictly adjusted by treating physicians based on clinical severity, renal clearance, and body weight.
10 × 10 Alu-Alu Strip in box with Dual Action protection shield
Store in a cool, dry place protected from moisture and direct light below 25°C
RexCure Pharmaceuticals Pvt. Ltd.
Hyderabad, Telangana
Healthcare practitioners and hospital pharmacies may request detailed product dossiers, bio-equivalence data, or clinic samples.
Contact Medical DeskDrug Law Compliance
Marketed under Drugs and Cosmetics Act, 1940 and Rules thereunder. Distributed exclusively through licensed pharmaceutical wholesalers and pharmacies.
Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)

Amoxicillin & Potassium Clavulanate Oral Suspension IP